🇺🇸 Spiriva® Respimat® 2,5 μg in United States

Spiriva® Respimat® 2,5 μg (Spiriva® Respimat® 2,5 μg) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Spiriva® Respimat® 2,5 μg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Spiriva® Respimat® 2,5 μg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Spiriva® Respimat® 2,5 μg in United States?

University Hospital, Bordeaux is the originator. The local marketing authorisation holder may differ — check the official source linked above.